BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Migliori GB, Wu SJ, Matteelli A, Zenner D, Goletti D, Ahmedov S, Al-Abri S, Allen DM, Balcells ME, Garcia-Basteiro AL, Cambau E, Chaisson RE, Chee CBE, Dalcolmo MP, Denholm JT, Erkens C, Esposito S, Farnia P, Friedland JS, Graham S, Hamada Y, Harries AD, Kay AW, Kritski A, Manga S, Marais BJ, Menzies D, Ng D, Petrone L, Rendon A, Silva DR, Schaaf HS, Skrahina A, Sotgiu G, Thwaites G, Tiberi S, Tukvadze N, Zellweger JP, D Ambrosio L, Centis R, Ong CWM. Clinical standards for the diagnosis, treatment and prevention of TB infection. Int J Tuberc Lung Dis 2022;26:190-205. [PMID: 35197159 DOI: 10.5588/ijtld.21.0753] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Heffernan C, Savić RM, Long RG, Raviglione MC, Ferrara G. Responding to the post-pandemic crisis: post-exposure prophylaxis for TB. Int J Tuberc Lung Dis 2022;26:807-10. [PMID: 35996295 DOI: 10.5588/ijtld.22.0342] [Reference Citation Analysis]
2 Saluzzo F, Denkinger CM, Cirillo DM. Improving interferon-γ release assay interpretation: are IP-10 and MIG the solution? Eur Respir J 2022;60:2200697. [PMID: 35948350 DOI: 10.1183/13993003.00697-2022] [Reference Citation Analysis]
3 Akkerman OW, Duarte R, Tiberi S, Schaaf HS, Lange C, Alffenaar JWC, Denholm J, Carvalho ACC, Bolhuis MS, Borisov S, Bruchfeld J, Cabibbe AM, Caminero JA, Carvalho I, Chakaya J, Centis R, Dalcomo MP, D Ambrosio L, Dedicoat M, Dheda K, Dooley KE, Furin J, García-García JM, van Hest NAH, de Jong BC, Kurhasani X, Märtson AG, Mpagama S, Torrico MM, Nunes E, Ong CWM, Palmero DJ, Ruslami R, Saktiawati AMI, Semuto C, Silva DR, Singla R, Solovic I, Srivastava S, de Steenwinkel JEM, Story A, Sturkenboom MGG, Tadolini M, Udwadia ZF, Verhage AR, Zellweger JP, Migliori GB. Clinical standards for drug-susceptible pulmonary TB. Int J Tuberc Lung Dis 2022;26:592-604. [PMID: 35768923 DOI: 10.5588/ijtld.22.0228] [Reference Citation Analysis]
4 Matteelli A, Alffenaar JC. Diagnosis and treatment of tuberculosis infection: can it contribute to achieving tuberculosis elimination? Eur Respir J 2022;60:2200540. [PMID: 35798372 DOI: 10.1183/13993003.00540-2022] [Reference Citation Analysis]
5 Alffenaar JWC, Stocker SL, Forsman LD, Garcia-Prats A, Heysell SK, Aarnoutse RE, Akkerman OW, Aleksa A, van Altena R, de Oñata WA, Bhavani PK, Van't Boveneind-Vrubleuskaya N, Carvalho ACC, Centis R, Chakaya JM, Cirillo DM, Cho JG, D Ambrosio L, Dalcolmo MP, Denti P, Dheda K, Fox GJ, Hesseling AC, Kim HY, Köser CU, Marais BJ, Margineanu I, Märtson AG, Torrico MM, Nataprawira HM, Ong CWM, Otto-Knapp R, Peloquin CA, Silva DR, Ruslami R, Santoso P, Savic RM, Singla R, Svensson EM, Skrahina A, van Soolingen D, Srivastava S, Tadolini M, Tiberi S, Thomas TA, Udwadia ZF, Vu DH, Zhang W, Mpagama SG, Schön T, Migliori GB. Clinical standards for the dosing and management of TB drugs. Int J Tuberc Lung Dis 2022;26:483-99. [PMID: 35650702 DOI: 10.5588/ijtld.22.0188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Castro KG, Ditiu L, Sahu S, Ntoumi F, Tiberi S, O'kane CM, Akkerman O, Manika K, Mwaba P, Davies Forsman L, Petersen E, Aklillu E, Azhar EI, Cirillo DM, Migliori G, Abbara A, Zumla A. Optimising tuberculosis care for refugees affected by armed conflicts. The Lancet Respiratory Medicine 2022;10:533-6. [DOI: 10.1016/s2213-2600(22)00104-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Migliori GB, Falzon D, Marks GB, Goletti D, Kasaeva T, Esposito S, Humbert M. Commemorating World Tuberculosis Day 2022: recent ERJ articles of critical relevance to ending TB and saving lives. Eur Respir J 2022;59:2200149. [PMID: 35332091 DOI: 10.1183/13993003.00149-2022] [Reference Citation Analysis]
8 Goletti D, Delogu G, Matteelli A, Migliori GB. The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. Int J Infect Dis 2022:S1201-9712(22)00126-6. [PMID: 35257904 DOI: 10.1016/j.ijid.2022.02.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]